Jan 29, 2024
Antibody-drug conjugates are revolutionizing the therapeutic
landscape for NSCLC. Are you up to date?
Credit available for this activity expires: 1/24/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999749?ecd=bdc_podcast_libsyn_mscpedu